Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

The expression and mutation of BRCA1/2 genes in ovarian cancer: a global systematic study.

Expert review of molecular diagnostics - 1 Jan 2023

Chu Dinh-Toi, Vu Ngoc Suong Mai, Vu Thi Hue, Vu Thuy-Duong, Nguyen Manh-Hung, Singh Vijai

Abstract excerpt

INTRODUCTION: This systematic review was designed to summarize the findings on expression and mutation of BRCA1/2 genes in ovarian cancer (OC) patients, focusing on mutation detection technology and taking clinical decisions for better treatment. AREAS COVERED: We conducted a systematic review by following the Preferred Reporting Items for Systematic Reviews and Meta-Analyses document selection guidelines for the...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to BRCA1 Protein
Share to BRCA2 Protein

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Breast Neoplasms

Share to Genes, BRCA1

Share to Genetic Predisposition to Disease

Share to High-Throughput Nucleotide Sequencing

Share to Mutation

Share to Ovarian Neoplasms

Source

Identifiers

PMID: 36634123
DOI: 10.1080/14737159.2023.2168190

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

The expression and mutation of BRCA1/2 genes in ovarian cancer: a global systematic study.PMID 36634123Read ↗

Detection of BRCA1/2 Mutation and Analysis of Clinicopathological Characteristics in 141 Cases of Ovarian Cancer.Semantic proximity Read ↗

BRCA mutations: Implications of genetic testing in ovarian cancer.Semantic proximity Read ↗

Mutational Screening of BRCA1/2 Genes as a Predictive Factor for Therapeutic Response in Epithelial Ovarian Cancer: A Consensus Guide from the Spanish Society of Pathology (SEAP-IAP) and the Spanish Society of Human Genetics (AEGH).Semantic proximity Read ↗

BRCA mutations in the manifestation and treatment of ovarian cancerSemantic proximity Read ↗

Clinical Evaluation of BRCA1/2 Mutation in Mexican Ovarian Cancer PatientsSemantic proximity Read ↗

Prevalence and clinical characterization of BRCA1 and BRCA2 mutations in Korean patients with epithelial ovarian cancer.Semantic proximity Read ↗

Analysis and comparison of BRCA1/2 gene mutations in 310 cases of ovarian cancerSemantic proximity Read ↗

BRCA mutation frequency and clinical features of ovarian cancer patients: A report from a Chinese study groupSemantic proximity Read ↗

The First Nationwide Multicenter Prevalence Study of Germline BRCA1 and BRCA2 Mutations in Chinese Ovarian Cancer PatientsSemantic proximity Read ↗

Next-generation sequencing-based genomic profiling analysis reveals novel mutations for clinical diagnosis in Chinese primary epithelial ovarian cancer patientsSemantic proximity Read ↗

[Recommendations for biomarker testing in epithelial ovarian cancer. A national consensus statement by the Spanish Society of Pathology and the Spanish Society of Medical Oncology].Semantic proximity Read ↗

Frequency of germline mutations in BRCA1 and BRCA2 in ovarian cancer patients and their effect on treatment outcomeSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.